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Background: Paneth cell metaplasia (PCM) is well described in adults but little is known about the distribution of
colonic Paneth cells and the occurrence of PCM in a paediatric population. The aim of this study is to determine
whether Paneth cell hyperplasia or metaplasia characteristically occurs in the colons of children with newly
diagnosed idiopathic inflammatory bowel disease (IBD).
Methods: We retrospectively reviewed colonic series from 28 new diagnoses of paediatric IBD at a tertiary referral
centre, and from a further 14 children with IBD-like symptoms whose colonic biopsies and ancillary investigations
were normal. Paneth cells were counted at 6 anatomical sites in the colon, and at each site acute and chronic
inflammation were assessed semi-quantitatively and the presence or absence of crypt architectural distortion and
eosinophilia was documented.
Results: In control, ulcerative colitis (UC) and Crohn’s disease (CD) groups there was a gradient of decreasing
Paneth cell numbers from caecum to rectum. Paneth cells were not seen in the distal colon in the control group,
but they were present there in 11 of 13 patients with ulcerative colitis and 14 of 15 with Crohn’s disease. Only
patients with IBD showed Paneth cell hyperplasia, assessed as more than 10 Paneth cells per 10 well-oriented crypts
at any site. There was a statistically significant increase in Paneth cells in the caecum, ascending, transverse and
descending colon in UC and in the ascending, transverse, descending and sigmoid colon in CD compared with
controls. There was no significant difference between UC and CD. There was no correlation between the site of
PCM and acute or chronic inflammation, crypt distortion or eosinophilia.
Conclusion: Paneth cells are found in the proximal but not the distal colon in otherwise normal paediatric colonic
series. A high proportion of UC and CD patients show PCM in the distal colon. This is present early in the disease
and does not correlate with histological features of chronicity.
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Paneth cells, named after Joseph Paneth [1], are unique
epithelial cells responsible for secreting the antimicrobial
alpha defensin peptides HD5 and HD6 as well as en-
zymes including lysozyme and phospholipase A2 that
act to keep the intestinal crypts sterile [2-7]. They play a
key role in defense against a broad range of intestinal
microbes and in the regulation of host immunity [8].
Paneth cells derive from fast-cycling crypt base colum-
nar cells, which are involved in crypt regeneration; they
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article, unless otherwise stated.from which they are eventually cleared by phagocytosis
[9,10]. Paneth cells are mostly located within the small
bowel; in adults they occur normally in smaller numbers
in the proximal large bowel (caecum to transverse
colon), but have been reported more distally only in
pathological states [11].
Paneth cells are termed ‘metaplastic’ when seen in
areas in which they are not normally found: Paneth cells
in the distal colon (descending colon, sigmoid and rec-
tum) are always metaplastic. In pathological states, an
increase in Paneth cell numbers – known as Paneth cell
hyperplasia – may occur in the proximal colon [11].
Paneth cell metaplasia (PCM) has been most often de-
scribed in idiopathic inflammatory bowel disease (IBD),tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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adults, it is thought to be a sign of a long colitis history: it
correlates with disease duration, and it has been attributed
to the effects of repair and regeneration [11-13]. Guide-
lines for reporting gastrointestinal biopsies published by
the British Society of Gastroenterology in 1997 [14] con-
curred that PCM was an indicator of chronic epithelial
cell damage, though it was not included in the data set for
IBD reporting as its diagnostic value was unclear. PCM
may be present in other pathological states – in neonates,
Paneth cell numbers are increased in the regenerating
bowel following necrotizing enterocolitis [15] – but is not
seen in self-limiting infectious colitides [16,17].
There have been few studies of PCM in paediatric
populations. IBD may present differently in this age
group: new presentations of ulcerative colitis in children
show a different pattern of inflammation from that seen
in adults [18]. In this study, we describe the distribution
of Paneth cells in symptomatic children without signifi-
cant gastrointestinal pathology, compare the findings
with newly diagnosed IBD, and evaluate the relation be-
tween PCM and histological features of chronic disease.
Methods
Selection of cases and controls
Cases in which a new diagnosis of IBD was made be-
tween 2005 and 2011 were drawn from the files of this
tertiary referral centre. Controls were supplied from
children with IBD-like symptoms (abdominal pain, diar-
rhoea, poor weight gain) whose colonic biopsies had
been reported as within normal limits. In all cases in-
formed patient consent was taken before endoscopy and
all six colonic sites plus the terminal ileum were biopsied
in all patients. Only those cases in which an unequivocal
diagnosis of UC or CD had been made by an experi-
enced pediatric pathologist (AWHB) after multidisciplin-
ary review of clinical and radiological findings were
selected for inclusion. The control patients had no evi-
dence of significant pathology: ancillary investigations
and any biopsies taken from sites outside the colon were
within normal limits, and none had been referred for re-
peat endoscopy due to persistent symptoms during at
least two years’ follow up. The data were collected as
part of an audit of histopathological reporting of gastro-
intestinal biopsies; no interventions were performed be-
yond normal clinical management and as such the study
did not require ethical approval.
Biopsy interpretation
Tissues were fixed in 4% paraformaldehyde and proc-
essed for light microscopy. Sections were cut at 6 μ
thickness and stained with haematoxylin and eosin.
Histological review of slides was performed using an
Olympus BH-2 microscope, high power field (HPF)diameter 0.5 mm2, magnification × 400. For each biopsy
site (caecum, ascending colon, transverse colon, de-
scending colon, sigmoid colon, rectum) the total number
of Paneth cells in the first ten well-orientated crypts was
counted by an experienced histopathologist (NS or
AWHB). This method was similar to that employed by
Kelly et al. [19]. Three cases scored by both pathologists
separately showed no significant interobserver variabil-
ity. In the sections in which Paneth cells were counted,
acute and chronic inflammation were scored semi-
quantitatively, as in routine histopathological practice.
Acute inflammation was defined as the presence of neu-
trophil polymorphs in surface or crypt epithelium or
crypt lumina and was scored as follows: 0 = no inflam-
mation, 1 =mild cryptitis, 2 = moderate cryptitis ± crypt
abscesses, 3 = severe cryptitis ± crypt abscesses or ulcer-
ation. Chronic inflammation was defined as increased
mucosal plasma cells or lymphoid aggregates and was
scored: 0 = no inflammation, 1 = increased basal plasma
cells, 2 = moderate increase in lamina propria plasma
cells ± lymphoid aggregates, 3 = dense lamina propria
plasma cells ± numerous lymphoid aggregates. Crypt
architectural distortion was recorded as present if there
was at least one of the following: crypt branching, cystic
dilatation, atrophy or irregular orientation. Otherwise, it
was recorded as absent. Eosinophil numbers within the
lamina propria were assessed as described previously
[20] and recorded as normal (<20 eosinophils/HPF) or
hypereosinophilia (>20 eosinophils/HPF).
Statistical analysis
Demographic information and histological features of in-
flammation at each anatomical site were compared be-
tween control, UC and CD groups using a chi-squared
test. Paneth cell counts were compared using a two-
sample Kolmogorov-Smirnov test. Correlation between
Paneth cell numbers and histological features of inflamma-
tion at each site was assessed by calculating Spearman’s
rank correlation coefficient.
Results
Clinical details and inflammation
A total of 28 cases with IBD (13 with UC and 15 with
CD) and 14 controls were examined (Table 1). The com-
monest documented symptoms were diarrhoea, abdom-
inal pain, rectal bleeding and weight loss. There was no
statistically significant difference in symptoms between
control, UC and CD groups. UC patients were more
likely to have received treatment with antiinflamma-
tories, infliximab, or immunosuppressants prior to histo-
logical diagnosis. All of the UC and CD patients had
abnormal endoscopic appearances compared with only
one of the controls, the histology of which showed lym-
phonodular hyperplasia. Extensive colitis and left-sided
Table 1 Symptoms and endoscopic appearances in controls and inflammatory bowel disease
Control UC CD
N 14 13 15
Sex (M/F) 10/4 6/7 5/10
Age range (median) 6-16 (12.5) 6-15 (14) 7-16 (13)
Symptoms: n (%) Diarrhoea 9 (64) 8 (62) 8 (53)
Abdominal pain 9 (64) 4 (31) 7 (47)
Rectal bleeding 6 (43) 10 (77) 6 (40)
Weight loss 4 (29) 6 (46) 2 (13)
Treatment prior to diagnosis: n (%) Antiinflammatories 2 (14) 7 (54)* 7 (47)
Infliximab 0 4 (31)* 0
Immunosuppressants 0 6 (46)† 1 (7)
Endoscopic appearance: n (%) Abnormal 1 (7)‡ 13 (100)§ 15 (100)§
Terminal ileitis 1 (7)‡ 0 5 (33)
Extensive colitis 0 7 (54)† 3 (20)
Discontinuous colitis 1 (7)‡ 1 (8) 7 (47)*
Left-sided colitis only 0 5 (38)* 0
Recto-sigmoid colitis only 0 2 (15) 0
*P < 0.05 (chi-squared) compared to controls.
†P < 0.005 compared to controls.
‡Histology showed lymphonodular hyperplasia.
§P < 0.00001 compared to controls.
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and discontinuous colitis was more common in Crohn’s
disease.
Paneth cell metaplasia
Paneth cells were identified in the caecum in 6 control
cases, in the ascending colon in 3 cases and the trans-
verse colon in one case, but none were present in the
distal colon (descending colon, sigmoid and rectum). In
patients with UC, Paneth cells were present in all but
one case, and in 11 of 13 cases they were present in theTable 2 Features of acute and chronic inflammation in contro
Highest acute inflammation score n (%) 0
1
2
3
Highest chronic inflammation score n (%) 0
1
2
3
Architectural distortion present (%)
Eosinophils > 20/HPF (%)
PCM (%)
*P < 0.05 (chi-squared).
†P < 0.005.
‡P < 0.00001.distal colon. In patients with CD, Paneth cells were
present in every case, and there were Paneth cells in the
distal colon in 14 of 15 cases. Table 2 summarises the
histological features of acute and chronic inflammation
in the three groups.
Patients with UC showed a significantly greater number
of Paneth cells in the caecum (P < 0.001), ascending colon
(P < 0.001), transverse colon (P < 0.006) and descending
colon (P < 0.001) compared with controls (Figure 1).
Patients with CD showed significantly more Paneth cells
in the ascending colon (P < 0.002), transverse colon (P <ls and inflammatory bowel disease
Control UC CD
14 (100) 0 0
0 2 (15) 9 (60)*
0 6 (46)† 2 (13)
0 5 (38)* 4 (27)*
10 (71) 0 0
4 (29) 0* 9 (60)*
0 7 (54)† 4 (27)*
0 6 (46)† 2 (13)
0 12 (92)‡ 13 (87)‡
1 (7) 6 (46)* 12 (80)†
0 11 (85)‡ 14 (93)‡
Figure 1 Numbers of Paneth cells (mean and 95% confidence interval) by site.
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(P < 0.001) compared with controls. There were no signifi-
cant differences in Paneth cell number at each anatomical
site between UC and CD groups.
Analysis of the features of each biopsy (n = 150) found
no correlation between Paneth cell number and the de-
gree of acute inflammation (Spearman’s rho = −0.036) or
chronic inflammation (rho = 0.057), and there was no
correlation with architectural distortion (rho = 0.025) or
eosinophilia (rho = 0.084). In IBD patients with PCM
considered separately there was no correlation between
numbers of metaplastic Paneth cells at each site and
scores for acute or chronic inflammation at these sites
(Figure 2, rho = −0.066 and −0.034, respectively).
Discussion
Paneth cells were found in almost half of the control
group in the caecum and ascending colon, and (rarely) the
transverse colon. This was comparable to the findings ofFigure 2 Numbers of Paneth cells (mean and 95% confidence intervathe study by Tanaka et al. in adults [11], which used
symptomatic patients as controls. We used a similar
methodology, as it was not feasible to obtain tissue from
asymptomatic children. Symptomatic controls were ap-
propriate for testing the hypothesis that Paneth cells are
a helpful diagnostic feature of newly-diagnosed paediat-
ric IBD, since this diagnosis is only considered in symp-
tomatic children. There was no evidence of significant
pathology in our control group: four children had a
focal non-specific mild increase in chronic inflamma-
tory cells in the lamina propria and the remaining ten
had no histological abnormality. Their symptoms were
most likely to have been due to irritable bowel syn-
drome. While we cannot entirely exclude IBD or other
colonic pathology having developed subsequently, this
is unlikely as re-referral for repeat colonoscopy is the
standard procedure if IBD-like symptoms persist, and
no patient in the control group had been re-referred
after a minimum of two years follow up. We concludel) in the distal colon in IBD in relation to local inflammation.
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children in the absence of significant disease. It is pos-
sible that altered bowel habit or other physiological
changes affected Paneth cell numbers in the control
group, so these findings are not necessarily applicable to
asymptomatic children. Treatment prior to referral may
also have modified Paneth cell numbers in both control
and IBD groups.
Despite these potential confounding factors, there
were clear differences between controls and IBD pa-
tients. Paneth cell numbers were significantly higher in
the proximal colon in IBD, which suggests that Paneth
cell hyperplasia occurs here. More than ten Paneth cells
per ten crypts at any site was seen only in IBD. PCM in
the distal colon was present in the great majority of pa-
tients with IBD. Paneth cell numbers were significantly
increased in IBD at all sites except the rectosigmoid in
UC and the caecum and rectum in CD, and even in
these areas Paneth cell counts were somewhat higher, so
it is likely that statistical significance would be achieved
with a larger series. One case of UC had no Paneth cells,
possibly due to their being patchily distributed, though
some colons may have no Paneth cells at all [11].
Paneth cells are implicated in both the pathogenesis of
and the response to IBD. Decreased Paneth cell activity
in the terminal ileum in a subset of patients with ileal
CD who have mutations of the susceptibility gene NOD2
may be an early or initiating factor in their disease
[6,7,21]. Alpha defensin expression, an indicator of Paneth
cell activity, is very low in the colon compared with the
normal terminal ileum, but it is raised in patients with
IBD, including children with colonic Crohn’s disease, pos-
sibly due to the presence of hyperplastic or metaplastic
Paneth cells [7]. Paneth cell hyperplasia and metaplasia
may be a local response to inflammatory changes in IBD,
or a reaction to pan-colonic changes such as altered bac-
terial flora [11]. Increased colonic Paneth cells in IBD may
be part of an adaptive reaction in which alpha defensins
constitute a protective barrier that helps prevent second-
ary mucosal infection in already inflamed bowel [22]. Al-
ternatively, it has been suggested that PCM in the colon
may exacerbate or even initiate IBD there [23]. The inter-
play of factors is complex and the role of Paneth cells in
the pathogenesis of colonic IBD remains unclear.
Kumarasinghe et al. [24] identified PCM in 2 of 25
(8%) cases of adult Crohn’s disease at initial presentation
but not in 5 patients with tuberculosis or diverticular
disease, which led them to suggest that PCM might be
an aid to the initial diagnosis of Crohn’s disease. The
present study shows that PCM is a feature of newly-
diagnosed IBD in children and is present in a high pro-
portion of cases at diagnosis: 85% of UC and 93% of CD
patients. In neither adults nor children is PCM specific
to IBD – for example, it has been demonstrated inchronic diverticulitis [25] and after necrotizing enterocoli-
tis [15] – but it may be be useful as an adjunct to the diag-
nosis of IBD in biopsies from symptomatic children.
Tanaka et al. [11] found a correlation between PCM and
crypt architectural distortion in adults and considered
PCM a feature of chronic IBD. In our paediatric patients
we found no correlation between PCM and histological
features of chronicity (increased lymphocytes, crypt archi-
tectural distortion), or between PCM and acute inflamma-
tion or eosinophilia. Since Paneth cells are renewed
approximately every 30 days, it is not possible to say from
our series whether PCM is present in IBD ab initio, since
the time between onset of symptoms and referral often
exceeded this. For practical purposes, however, since PCM
is seen in a high proportion of cases of paediatric IBD at
the time of diagnosis it is not specific for established dis-
ease. A follow-up study of Paneth cell numbers in a paedi-
atric population with longstanding IBD is planned to
determine whether their numbers and distribution change
as disease progresses.
Conclusions
PCM is present in most cases of paediatric IBD at the time
of diagnosis. It does not correlate with histological features
of chronic inflammation and does not appear to be a sign
of chronicity. We recommend that the presence of PCM
(Paneth cells in the distal colon) or hyperplasia (>10
Paneth cells per 10 crypts in the proximal colon) should
be reported in paediatric colonoscopy series as they are
features suggestive though not diagnostic of IBD.
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